Cargando…

The Effect of Low Dose OnabotulinumtoxinA on Cervical Dystonia in Hypermobile Ehlers-Danlos Syndrome

BACKGROUND: Many patients with hypermobile Ehlers-Danlos Syndrome (EDS) suffer from cervical dystonia. Intramuscular injection of botulinum toxin may exacerbate myeloradiculopathy or atlantoaxial subluxation in this patient population. CASE: Three patients with hypermobile EDS underwent low-dose Ona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tina J., Stecco, Antonio, Dashtipour, Khashayar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555620/ https://www.ncbi.nlm.nih.gov/pubmed/34754601 http://dx.doi.org/10.5334/tohm.647

Ejemplares similares

Change in gliding properties of the iliotibial tract in hypermobile Ehlers–Danlos Syndrome
por: Wang, Tina J., et al.
Publicado: (2023)

Gastrointestinal Symptoms in Marfan Syndrome and Hypermobile Ehlers-Danlos Syndrome
por: Inayet, N., et al.
Publicado: (2018)

The Impact of Hypermobile “Ehlers-Danlos Syndrome” and Hypermobile Spectrum Disorder on Interpersonal Interactions and Relationships
por: De Baets, Stijn, et al.
Publicado: (2022)

Application of immunotherapy for neurological manifestations in hypermobile Ehlers–Danlos syndrome
por: Araki, Manabu, et al.
Publicado: (2018)

Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome
por: Forghani, Irman
Publicado: (2019)

Spontaneous Diaphragmatic Rupture in Hypermobile Type Ehlers-Danlos Syndrome
por: Amin, Ruchi, et al.
Publicado: (2017)

OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Cleidocranial dysplasia with hypermobile Ehlers-Danlos syndrome: A case report
por: Ibrahim, Rengin, et al.
Publicado: (2022)

Improvement in Quality of Life with OnabotulinumtoxinA for Cervical Dystonia: POSTURe
por: Petitclerc, Marc, et al.
Publicado: (2021)

Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes
por: Chiarelli, Nicola, et al.
Publicado: (2019)

Are patients with hypermobile Ehlers–Danlos syndrome or hypermobility spectrum disorder so different?
por: Aubry-Rozier, Bérengère, et al.
Publicado: (2021)

Small fiber neuropathy in hypermobile Ehlers Danlos syndrome/hypermobility spectrum disorder
por: Fernandez, Aurore, et al.
Publicado: (2022)

Multichannel Electromyographic Mapping to Optimize OnabotulinumtoxinA Efficacy in Cervical Dystonia
por: Kilbane, Camilla, et al.
Publicado: (2012)

Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Jankovic, Joseph, et al.
Publicado: (2023)

Arthroscopic Capsular Plication for Multidirectional Shoulder Instability in Hypermobile Ehlers-Danlos Syndrome Patients
por: Housset, Victor, et al.
Publicado: (2021)

Hypermobile Ehlers–Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know
por: Thwaites, Phoebe A, et al.
Publicado: (2022)

Habituation deficit of visual evoked potentials in migraine patients with hypermobile Ehlers-Danlos syndrome
por: Maestrini, Ilaria, et al.
Publicado: (2023)

Dermal Ultrastructure in Low Beighton Score Members of 17 Families with Hypermobile-Type Ehlers-Danlos Syndrome
por: Hermanns-Lê, Trinh, et al.
Publicado: (2012)

Use of complementary and alternative medicine by patients with hypermobile Ehlers–Danlos Syndrome: A qualitative study
por: Doyle, Tom A., et al.
Publicado: (2022)

A novel method of assessing balance and postural sway in patients with hypermobile Ehlers-Danlos syndrome
por: Whitmore, Miguel, et al.
Publicado: (2023)

High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia
por: Marsh, Wallace A, et al.
Publicado: (2014)

Pain Management through Neurocognitive Therapeutic Exercises in Hypermobile Ehlers–Danlos Syndrome Patients with Chronic Low Back Pain
por: Celletti, Claudia, et al.
Publicado: (2021)

Craniofacial Morphology and Upper Airway Dimensions in Patients with Hypermobile Ehlers-Danlos Syndrome Compared to Healthy Controls
por: Sonnesen, Liselotte, et al.
Publicado: (2021)

Rectal hyposensitivity: a common pathophysiological finding in patients with constipation and associated hypermobile Ehlers–Danlos syndrome
por: Choudhary, Anisa, et al.
Publicado: (2022)

Central sensitization in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome—a feasibility study
por: Schubert-Hjalmarsson, Elke, et al.
Publicado: (2023)

Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin(®))
por: Dressler, Dirk, et al.
Publicado: (2013)

Hypermobile Ehlers-Danlos syndrome and rehabilitation: taking stock of evidence based medicine: a systematic review of the literature
por: Corrado, Bruno, et al.
Publicado: (2018)

Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Hypermobile Ehlers-Danlos Syndrome: A Tertiary Care Center Experience
por: Alomari, Mohammad, et al.
Publicado: (2020)

Muscle Strength, Muscle Mass and Physical Impairment in Women with hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorder
por: Coussens, Marie, et al.
Publicado: (2022)

Anorectal manometry for the diagnosis of pelvic floor disorders in patients with hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome
por: Zhou, Wendy, et al.
Publicado: (2022)

A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice
por: Feldman, Estée C.H., et al.
Publicado: (2023)

Childbearing with Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders: A Large International Survey of Outcomes and Complications
por: Pearce, Gemma, et al.
Publicado: (2023)

Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II
por: Kent, Ruth, et al.
Publicado: (2021)

Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)
por: Charles, P. David, et al.
Publicado: (2014)

Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia
por: Misra, V. P., et al.
Publicado: (2020)

Evaluating the effects of two different kinesiology taping techniques on shoulder pain and function in patients with hypermobile Ehlers-Danlos syndrome
por: Tudini, Frank, et al.
Publicado: (2023)

The role of gene encoding collagen secretion protein (SERPINH1) in the pathogenesis of a hypermobile type of Ehlers-Danlos syndrome
por: Junkiert-Czarnecka, Anna, et al.
Publicado: (2023)

Co-Created Solutions for Perinatal Professionals and Childbearing Needs for People with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders
por: Pearce, Gemma, et al.
Publicado: (2023)

The Language of Pain in the Hypermobile Ehlers–Danlos Syndrome: Metaphors as a Key to Understanding the Experience of Pain and as a Rehabilitation Tool
por: Camerota, Filippo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g79bunrbnousm4bn5pkgga9vu1